SCHEMBL7682464

SCHEMBL7682464

CCCCC(NC(=O)c1ccc(SCc2ccc3ccccc3c2)cc1)C(=O)CNS(C)(=O)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.42
CCKBR P32239 1/20 0.41
DHFR P00374 4/20 0.40
FPGS Q05932 2/20 0.40
CTSL P07711 1/20 0.39
CTSB P07858 1/20 0.39
CTSS P25774 1/20 0.39
CTSK P43235 1/20 0.39
LTB4R Q15722 1/20 0.38
HDAC3 O15379 2/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC2 Q92769 2/20 0.37
NCOR1 O75376 1/20 0.37
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
RECQL P46063 1/20 0.36
PLA2G2A P14555 2/20 0.36
PLA2G10 O15496 1/20 0.36
MCHR1 Q99705 1/20 0.36
MAPK14 Q16539 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7686484 0.91 CA2 (0.44) CA2CCKBRDHFRFPGSCTSL
SCHEMBL7666410 0.88 CCKBR (0.42) CA2CCKBRDHFRFPGSCTSL
SCHEMBL7661370 0.88 CCKBR (0.44) CA2CCKBRDHFRFPGSCTSL
SCHEMBL7701294 0.88 CA2 (0.50) CA2CTSLCTSBCTSSCTSK
SCHEMBL7420467 0.85 PTPN1 (0.45) CA2CCKBRDHFRFPGSCTSL
SCHEMBL7428036 0.83 CA2 (0.45) CA2CCKBRHDAC3HDAC1HDAC2
SCHEMBL7425669 0.80 ALDH1A1 (0.52) CA2CCKBRHDAC3HDAC1HDAC2
SCHEMBL7704769 0.78 CA2 (0.52) CA2CTSLCTSBCTSSCTSK
SCHEMBL7678439 0.76 ADAMTS4 (0.48) CA2CCKBRDHFRFPGSMAPT
SCHEMBL7391842 0.75 HDAC8 (0.46) CA2CCKBRMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed